Dopamine Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Dopamine Hydrochloride Injection (injection) from Hospira, Inc., A Pfizer Company with status Current. The shortage was first posted on Nov 6, 2017.
Shortage details
- Status
- Current
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0409-0042-12
- Dosage Form
- Injection
- Presentation
- Dopamine Hydrochloride In Dextrose 5% In Plastic Container, Injection, 400 mg/250 mL (1.6 mg/1 mL) (NDC 0409-0042-12)
- Initial Posting
- Nov 6, 2017